ApoA1 has been found at decreased levels in subjects with a variety of neurodegenerative disorders including in the serum and cerebrospinal fluid of Alzheimer disease, Parkinson disease and DS with gout subjects. This evidence concerns the gene APOA1 and early-onset autosomal dominant Alzheimer disease.